Literature DB >> 149049

Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy.

N Egberg, K Bergström.   

Abstract

Chromogenic substrates were used to assay prekallikrein, prothrombin and factor X. Plasma prekallikrein was contact activated and allowed the splitting of HD-Pro-Phe-Arg-PNA which has affinity for plasma kallikrein. Prothrombin was assayed in various ways (immunologically, after activation with Ecarin or in a less specific way). Determination of factor X is considered as a possible specific method in the monitoring of coumarol therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 149049     DOI: 10.1159/000214240

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  2 in total

1.  Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.

Authors:  M Hellgren; N Egberg; J Eklund
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

2.  A new chromogenic assay for the specific determination of prothrombin.

Authors:  J L Francis
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.